Release of antifungal agent Turbine tablets
The sale of Turbine tablets, an antifungal agent belonging to the Allyamine family, began on December 1.
Turbine tablets inhibit squalene epoxidase, which is a step earlier than other azole antifungal agents, and squalene accumulates within cells, which has a fungicidal effect on fungi. In addition, due to the lack of ergosterol, it also exhibits antifungal action and has excellent effects.
Terbin Tab.
● Ingredient content Terbinafine Hydrochloride 140.625mg/1Tab
(Terbinafine 125mg)
● Classification number 629/antifungal agents
● Insurance code A17603711
● Efficacy and effect
Adult 1. Dermatophytosis such as: tinea pedis, tinea capitis, tinea corporis
2. Onychomycosis
Pediatric tinea capitis
● Dosage and dosage
Adults: Administer 125 mg twice a day or 250 mg once a day.
1. Dermatophytosis
- Tinea pedis (interphalangeal type, plantar type/moccasin type) 2-6 weeks
- Tinea capitis (jock itch) 2-4 weeks
- Tinea corporis 4 weeks
2. Onychomycosis
Typically administered for 6 weeks to 3 months
Children over 2 years of age
Weight less than 20 kg - once a day, administer 62.5 mg once
Body weight 20-40kg - once a day, administer 125mg once a time
Weight exceeding 40kg - Administer 250mg once a day
- Tinea capitis 4 weeks
Tinea capitis mainly occurs in children.
To prevent recurrence of infection, treatment must be performed regularly and for an appropriate period of time.
● Standard drug price 649 won
● Packaging unit 100T, 300T